We here demonstrated that LASS2 overexpression significantly down-regulated the expression of N-cadherin while increasing that of E-cadherin both in vitro and in vivo, suggesting that LASS2 can function by inhibiting glioma/glioblastoma growth partly via the suppression of EMT. This evidence concerns the gene CERS2 and central nervous system cancer.